GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,050,000 | +1.4% | 24,126 | +1.5% | 0.03% | +13.0% |
| Q1 2022 | $1,036,000 | -5.5% | 23,779 | -4.3% | 0.02% | -4.2% |
| Q4 2021 | $1,096,000 | +45.2% | 24,860 | +25.8% | 0.02% | +26.3% |
| Q3 2021 | $755,000 | +3.6% | 19,761 | +7.9% | 0.02% | +5.6% |
| Q2 2021 | $729,000 | +14.1% | 18,306 | +2.3% | 0.02% | 0.0% |
| Q1 2021 | $639,000 | -4.8% | 17,899 | -1.8% | 0.02% | -10.0% |
| Q4 2020 | $671,000 | -10.5% | 18,224 | -8.6% | 0.02% | -20.0% |
| Q3 2020 | $750,000 | -3.8% | 19,933 | +4.2% | 0.02% | -10.7% |
| Q2 2020 | $780,000 | +6.3% | 19,127 | -1.3% | 0.03% | -17.6% |
| Q1 2020 | $734,000 | -5.4% | 19,372 | +17.3% | 0.03% | +13.3% |
| Q4 2019 | $776,000 | +12.5% | 16,520 | +2.2% | 0.03% | 0.0% |
| Q3 2019 | $690,000 | +1.5% | 16,160 | -4.9% | 0.03% | +3.4% |
| Q2 2019 | $680,000 | -9.7% | 16,992 | -5.7% | 0.03% | -14.7% |
| Q1 2019 | $753,000 | +32.8% | 18,010 | +21.4% | 0.03% | +17.2% |
| Q4 2018 | $567,000 | -4.1% | 14,832 | +0.7% | 0.03% | +11.5% |
| Q3 2018 | $591,000 | +2.2% | 14,724 | +2.7% | 0.03% | 0.0% |
| Q2 2018 | $578,000 | -15.9% | 14,337 | -18.5% | 0.03% | -10.3% |
| Q1 2018 | $687,000 | +29.1% | 17,591 | +17.2% | 0.03% | +20.8% |
| Q4 2017 | $532,000 | -30.5% | 15,006 | -20.5% | 0.02% | -33.3% |
| Q3 2017 | $766,000 | -20.9% | 18,869 | -16.0% | 0.04% | -28.0% |
| Q2 2017 | $968,000 | +9.5% | 22,453 | +7.1% | 0.05% | 0.0% |
| Q1 2017 | $884,000 | +93.0% | 20,971 | +76.4% | 0.05% | +78.6% |
| Q4 2016 | $458,000 | -31.7% | 11,887 | -23.6% | 0.03% | -37.8% |
| Q3 2016 | $671,000 | +23.1% | 15,564 | +23.7% | 0.04% | +12.5% |
| Q2 2016 | $545,000 | +21.4% | 12,582 | +13.7% | 0.04% | +2.6% |
| Q1 2016 | $449,000 | -57.1% | 11,064 | -57.3% | 0.04% | -55.2% |
| Q4 2015 | $1,047,000 | -16.7% | 25,941 | -20.6% | 0.09% | -44.9% |
| Q3 2015 | $1,257,000 | -18.2% | 32,660 | -11.5% | 0.16% | -19.8% |
| Q2 2015 | $1,537,000 | +14.3% | 36,902 | +26.5% | 0.20% | +23.1% |
| Q1 2015 | $1,345,000 | +41.7% | 29,162 | +31.4% | 0.16% | -6.4% |
| Q4 2014 | $949,000 | +2.5% | 22,195 | +10.3% | 0.17% | -21.2% |
| Q3 2014 | $926,000 | -6.5% | 20,130 | +8.9% | 0.22% | -34.2% |
| Q2 2014 | $990,000 | – | 18,481 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |